1. World Health Organization (WHO) (2004) Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. WHO, Geneva, Switzerland. Available online at: http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf
2. Panel on clinical practices for the treatment of HIV infection, convened by the DHHS (2008) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, January 29, 2008. Available online at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
3. Panel on clinical practices for the treatment of HIV infection, convened by the DHHS (2008) Guidelines for the use of antiretroviral agents in pediatric HIV infection, February 28, 2008. Available online at: http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf
4. Egger M, May M, Chêne G, Philips AN, Ledergerber B, Dabis F, Costagliola D, D’Arminio Monforte A, de Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JA; ART Cohort Collaboration (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360:119–129
5. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F (2001) Overview of the effectiveness of triple combination therapy in antiretroviral-naïve HIV-1 infected adults. AIDS 15:1369–1377